You may have heard that there is a new injectable treatment to eliminate the dreaded “double chin.” The product is known as KYBELLA in the U.S. and BELKYRA here in Canada. BELKYRA was recently approved by Health Canada for the treatment of submental fullness, or fat below the chin.
This is the only FDA and Health Canada approved non-surgical treatment to reduce submental fat. The active ingredient in BELKYRA is deoxycholic acid, which is a naturally occurring molecule in the body that helps with the breakdown and absorption of fat. When injected, it causes the destruction of fat cells so that those cells can no longer store fat.
Because BELKYRA destroys fat cells, once the desired aesthetic appearance is achieved it is not expected that any re-treatment will be needed. However, the initial treatment regimen will be tailored based on your profile and the desired contouring of the chin. It may require up to six treatments each one-month apart, though results have been seen in as few as two treatments.
Many adults, both men and women, have expressed unhappiness with the appearance of a double chin. That is why it is very exciting to be able to offer a non-invasive treatment that can provide patients with significant results in a short amount of time. The procedure has minimal patient downtime and common side effects are similar to other injectables, including possible swelling, bruising and pain at the site of injection.